• 2018 Distinguished Lectureship Award Winners to Present Talks at Experimental Biology:  Released April 17, 2018 - The American Physiological Society (APS) has announced the 2018 recipients of its distinguished lecturer awards. APS is pleased to recognize these outstanding honorees, who will present their lectures at the APS annual meeting at Experimental Biology 2018 (April 21–25 in San Diego).
  • Nobel Laureate, Top Researchers Talk Exosomes in President’s Symposium Series:  APS President Dennis Brown, PhD, of Harvard Medical School and Massachusetts General Hospital, has organized a thought-provoking President’s Symposium Series for the American Physiological Society (APS) annual meeting at Experimental Biology 2018 in San Diego. Three symposia will focus on the theme “Exosomes: The New Frontier.” Top researchers in physiology will discuss the biology and pathophysiology of exosomes—tiny structures secreted from cells and found in many body fluids—as well as the use of exosomes as diagnostic and therapeutic tools. The series concludes on Wednesday with the prestigious Nobel Prize in Physiology or Medicine Lecture by Nobel Laureate Leland Hartwell, PhD, director of the Biodesign Institute at Arizona State University.
  • Distracted by Social Media, But Students Are Still Listening:  A new study finds that social media distraction in the classroom interferes with visual, but not auditory, learning in college students. The paper is published in Advances in Physiology Education.
  • Resistance Exercise Improves Insulin Resistance, Glucose Levels:  A new study suggests that resistance exercise may improve indicators of type 2 diabetes by increasing expression of a protein that regulates blood sugar (glucose) absorption in the body. The paper, published ahead of print in the American Journal of Physiology—Endocrinology and Metabolism, was chosen as an APSselect article for April.
  • Opioids No More? Review Article Evaluates Alternative Treatments for Chronic Pain:  An estimated 2 million people in the U.S. are addicted to prescription opioids—powerful doctor-prescribed medications for chronic or severe pain. The drugs are commonly prescribed to treat gastrointestinal pain caused by conditions such as Crohn’s disease and irritable bowel syndrome (IBS), raising the risk of addiction among this population. A review published ahead of print in the American Journal of Physiology—Gastrointestinal and Liver Physiology explores newer, potentially safer therapies for treating chronic abdominal pain with lower risks of addiction and side effects.
  • More...